MoneyWorks4Me

Cipla informs about press release

10 May 2021 Evaluate

Cipla has informed that it has enclosed press release dated 10th May 2021 titled ‘Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1749.20
Dr. Reddys Labs. 1232.90
Cipla 1330.50
Lupin 1964.50
Zydus Lifesciences 1121.75
View more..